Compound ID | 1618
Class: Nucleoside analog
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Compound shows activity against B. subtilis, L. mesenteroides, S. aureus, M. smegmatis, E.coli and P. aeruginosa |
| Institute where first reported: | Russian Academy of Sciences, Moscow, Russia |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://www.nature.com/articles/s41429-019-0158-z |